Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 2 3Phase 1/2 1

Status

Recruiting 2Completed 2Withdrawn 1Unknown 1Terminated 1Active not recruiting 1

Sponsor Class

OTHER 7INDUSTRY 1

Study Type

Interventional 8

Sponsor

Cancer Type

Breast 8Lymphoid 1

Conditions

Carcinoma, Hepatocellular 44Neoplasm Metastasis 19Liver Neoplasms 18Colorectal Neoplasms 15Cholangiocarcinoma 11Pancreatic Neoplasms 9Lung Neoplasms 9Colonic Neoplasms 9Breast Neoplasms 8Carcinoma, Renal Cell 7Carcinoma, Non-Small-Cell Lung 7Barrett Esophagus 7Thyroid Nodule 6Recurrence 6Rectal Neoplasms 6Thyroid Neoplasms 5Pain 4Neoplasms 4Kidney Neoplasms 4Esophageal Neoplasms 4Thyroid Cancer, Papillary 3Prostatic Neoplasms 3Leiomyoma 3Biliary Tract Neoplasms 3Bile Duct Neoplasms 3Agnosia 3Thyroid Diseases 2Hyperaldosteronism 2Hepatitis B 2Gallbladder Neoplasms 2

Interventions

Trastuzumab 625Paclitaxel 576Cyclophosphamide 555Docetaxel 484Capecitabine 401Letrozole 376Fulvestrant 326Doxorubicin 294Carboplatin 279Tamoxifen 275Anastrozole 243exemestane 228Radiotherapy 218Epirubicin 211Bevacizumab 196palbociclib 189pertuzumab 184Vinorelbine 167Lapatinib 167Gemcitabine 166pembrolizumab 162Surveys and Questionnaires 138Exercise 136Magnetic Resonance Spectroscopy 123Fluorouracil 119Blood Specimen Collection 118eribulin 117Albumin-Bound Paclitaxel 117Drug Therapy 111130-nm albumin-bound paclitaxel 111

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
Breast Neoplasms × Radiofrequency Ablation × Clear all
NCT07206121 2026-02-11

Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery

Innoblative Designs, Inc.

Phase NA Recruiting
10 enrolled
BreastLymphoid

Breast Neoplasms, Lymphoma, Follicular

NCT01153035 2025-11-10

ABLATE

University of Arkansas

Phase NA Active not recruiting
104 enrolled
Breast

Breast Neoplasms

NCT04698252 2022-08-08

LARA

Instituto do Cancer do Estado de São Paulo

Phase 2 Recruiting
74 enrolled
Breast

Breast Neoplasms

NCT03750396 2019-02-15

CLEAR

Gangnam Severance Hospital

Phase 2 Unknown
110 enrolled
Breast

Breast Neoplasms

NCT02281812 2018-06-04

Radiofrequency Ablation in Breast Cancer

Hospital Universitari de Bellvitge

Phase NA Terminated
40 enrolled
Breast

Breast Neoplasms

NCT00373152 2017-12-05

MRI in Predicting Tumor Reponse After Radiofrequency Ablation in Women With Invasive Breast Cancer

Masonic Cancer Center, University of Minnesota

Phase 2 Withdrawn
Breast

Breast Neoplasms

NCT00574301 2013-07-25

Percutaneous Removal and Margin Ablation for Breast Cancer

University of Arkansas

Phase 1/2 Completed
32 enrolled
Breast

Breast Neoplasms

NCT00388115 2010-03-29

Radiofrequency Ablation in Treating Patients With Early Invasive Breast Cancer or Ductal Carcinoma in Situ

University of California, Davis

Phase NA Completed
15 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡